Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoRecormon for Cardiac Ischemia in CPB
NCT00273767Phase 2Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jan 2006
- Primary completion
- Jul 2009
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Myocardial ischemia (MI) comparing NeoRecormon with Placebo (2 arms). Primary endpoints: Troponin-T Level, N-terminal pro-brain natriuretic peptide and 1 more. Started Jan 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT00273767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273767.